The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Oxytocin Infusion Reduces Repetitive Behaviors in Adults with Autistic and Asperger's Disorders
Abstract
Autism is a neurodevelopmental disorder characterized by dysfunction in three core behavioral domains: repetitive behaviors, social deficits, and language abnormalities. There is evidence that abnormalities exist in peptide systems, particularly the oxytocin system, in autism spectrum patients. Furthermore, oxytocin and the closely related peptide vasopressin are known to play a role in social and repetitive behaviors. This study examined the impact of oxytocin on repetitive behaviors in 15 adults with autism or Asperger's disorder via randomized double-blind oxytocin and placebo challenges. The primary outcome measure was an instrument rating six repetitive behaviors: need to know, repeating, ordering, need to tell/ask, self-injury, and touching. Patients with autism spectrum disorders showed a significant reduction in repetitive behaviors following oxytocin infusion in comparison to placebo infusion. Repetitive behavior in autism spectrum disorders may be related to abnormalities in the oxytocin system, and may be partially ameliorated by synthetic oxytocin infusion.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Improvements in repetitive behaviors in adults with autism following oxytocin infusion have been demonstrated [169] as well as positive effects on social behaviors and cognition [170].”
From Consensus Paper: Pathological Role of the Cerebellum in Autism (2012) · cites this paper as [169]
In the citing paper
“The neuromodulator oxytocin (OT) has been shown to improve social deficits in both ASD and other disorders accompanied by social deficits (Guastella et al., 2010, 2010; Hollander et al., 2002, 2007; Yatawara et al., 2015; Young and Barrett, 2015).”
From Oxytocin enhances gaze-following responses to videos of natural social behavior in adult male rhesus monkeys (2016) · cites this paper as Hollander et al., 2002
In the citing paper
“reduce repetitive behaviors (Hollander et al., 2003)”
From Effects of intranasal oxytocin on social anxiety in males with fragile X syndrome (2012) · cites this paper as Hollander et al., 2003
In the citing paper
“This study demonstrated that administration of OT led to a decrease in a core ASD symptom, RRB.”
From Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders (2014) · cites this paper as Hollander et al., 2003
In the citing paper
“Overall, these observed effects on repetitive behaviors are in line with previous trials with adult men with ASD showing beneficial effects of OT on repetitive behaviors after 4 h of intravenous OT administration [4] and after 6 weeks of daily administrations [8, 10].”
From Behavioral effects of multiple-dose oxytocin treatment in autism: a randomized, placebo-controlled trial with long-term follow-up (2020) · cites this paper as [4]
In the citing paper
“In this view, it appears that beneficial effects of OT treatment on repetitive behaviors were mostly demonstrated in studies that adopted assessments based on self-reports (current study, [4, 8]), whereas no beneficial effects were evident in studies adopting informant-based reports of repetitive behavior [9–14].”
From Behavioral effects of multiple-dose oxytocin treatment in autism: a randomized, placebo-controlled trial with long-term follow-up (2020) · cites this paper as [4]
In the citing paper
“There is both animal (Popik et al., 1992) and human (Hollander et al., 2007(Hollander et al., , 2003) ) research to suggest systemic OT can influence social behavior and cognition”
From Low dose intranasal oxytocin delivered with Breath Powered device dampens amygdala response to emotional stimuli: A peripheral effect-controlled within-subjects randomized dose-response fMRI trial (2016) · cites this paper as Hollander et al., 2003
In the citing paper
“oxytocin , relative to placebo, reduces repetitive stereotypic behaviors [172]”
From Social “wanting” dysfunction in autism: neurobiological underpinnings and treatment implications (2012) · cites this paper as [172]
Citations
Cites
Lord, C., Rutter, M., & Le Couteur, A. (1994) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02172145 · Cited by 9,065
The neurobiology of attachment
Insel, T. R., & Young, L. J. (2001) · Nature Reviews Neuroscience · doi:10.1038/35053579 · Cited by 1,173
Social amnesia in mice lacking the oxytocin gene
Ferguson, J. N., Young, L. J., Hearn, E. F., Matzuk, M. M., Insel, T. R., & Winslow, J. T. (2000) · Nature Genetics · doi:10.1038/77040 · Cited by 1,130
A role for central vasopressin in pair bonding in monogamous prairie voles
Winslow, J. T., Hastings, N., Carter, C. S., Harbaugh, C. R., & Insel, T. R. (1993) · Nature · doi:10.1038/365545a0 · Cited by 948 · cited 1×
“For males, vasopressin has been shown to evoke partner preference and aggression after mating (Winslow et al, 1993).”
BackgroundOxytocin is required for nursing but is not essential for parturition or reproductive behavior.
Nishimori, K., Young, L. J., Guo, Q., Wang, Z., Insel, T. R., & Matzuk, M. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11699 · Cited by 734
Plasma oxytocin levels in autistic children
Modahl, C., Green, L. A., Fein, D., Morris, M., Waterhouse, L., Feinstein, C., & Levin, H. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00439-3 · Cited by 728
Insel, T. R., & Hulihan, T. J. (1995) · Behavioral Neuroscience · doi:10.1037/0735-7044.109.4.782 · Cited by 528
Oxytocin and autistic disorder: alterations in peptide forms
Green, L., Fein, D., Modahl, C., Feinstein, C., Waterhouse, L., & Morris, M. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01139-8 · Cited by 404
Behavioral effects of intraventricularly administered vasopressin and vasopressin fragments
de Wied, D. (1976) · Life Sciences · doi:10.1016/0024-3205(76)90165-x · Cited by 359
Central Nervous System Effects of the Neurohypophyseal Hormones and Related Peptides
de Wied, D., Diamant, M., & Fodor, M. (1993) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1993.1009 · Cited by 327
Cited by
Sorted by citations
Items 301–400 of 704
Pediatric Traumatic Brain Injury and Autism: Elucidating Shared Mechanisms
Singh, R. S., Turner, R. C., Nguyen, L., Motwani, K., Swatek, M., & Lucke-Wold, B. P. (2016) · Behavioural Neurology · doi:10.1155/2016/8781725 · Cited by 41
Sniffing oxytocin: Nose to brain or nose to blood?
Yao, S., Chen, Y., Zhuang, Q., Zhang, Y., Lan, C., Zhu, S., Becker, B., & Kendrick, K. M. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02075-2 · Cited by 41
Yang, C.-J., Tan, H.-P., Yang, F.-Y., Wang, H.-P., Liu, C., He, H., Sang, B., Zhu, X.-M., & Du, Y. (2015) · Research in Autism · doi:10.1016/j.rasd.2015.07.002 · Cited by 41
Lin, I.-F., Kashino, M., Ohta, H., Yamada, T., Tani, M., Watanabe, H., Kanai, C., Ohno, T., Takayama, Y., Iwanami, A., et al. (2014) · Molecular Autism · doi:10.1186/2040-2392-5-20 · Cited by 40
Spectrum of effectiveness of valproate in neuropsychiatry
Bowden, C. L. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.1.9 · Cited by 40
Schechter, M., Pinhasov, A., Weller, A., & Fride, E. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.10.016 · Cited by 40
Post-traumatic stress disorder: emerging concepts of pharmacotherapy
Baker, D. G., Nievergelt, C. M., & Risbrough, V. B. (2009) · Expert Opinion on Emerging Drugs · doi:10.1517/14728210902972494 · Cited by 39
Lamy, M., Pedapati, E. V., Dominick, K. C., Wink, L. K., & Erickson, C. A. (2020) · Pediatric Drugs · doi:10.1007/s40272-020-00408-0 · Cited by 39
Wong, J. C., Shapiro, L. E., Thelin, J. T., Heaton, E. C., Zaman, R. U., D’Souza, M. J., Murnane, K. S., & Escayg, A. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105147 · Cited by 39
Kou, J., Lan, C., Zhang, Y., Wang, Q., Zhou, F., Zhao, Z., Montag, C., Yao, S., Becker, B., & Kendrick, K. M. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01241-w · Cited by 39
Kojima, S., & Alberts, J. R. (2011) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.08.003 · Cited by 39
Anticonvulsants in Bipolar Disorder
Bowden, C. L., & Karren, N. U. (2006) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2006.01815.x · Cited by 39
CD38 regulates oxytocin secretion and complex social behavior
Bartz, J. A., & McInnes, L. A. (2007) · BioEssays · doi:10.1002/bies.20623 · Cited by 39
Melanin concentrating hormone modulates oxytocin-mediated marble burying
Sanathara, N. M., Garau, C., Alachkar, A., Wang, L., Wang, Z., Nishimori, K., Xu, X., & Civelli, O. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.09.008 · Cited by 38
A peek inside the neurosecretory brain through Orthopedia lenses
Giacco, L. D., Pistocchi, A., Cotelli, F., Fortunato, A. E., & Sordino, P. (2008) · Developmental Dynamics · doi:10.1002/dvdy.21668 · Cited by 38
Associations between oxytocin-related genes and autistic-like traits
Hovey, D., Zettergren, A., Jonsson, L., Melke, J., Anckarsäter, H., Lichtenstein, P., & Westberg, L. (2014) · Social Neuroscience · doi:10.1080/17470919.2014.897995 · Cited by 37
Beard, R., Singh, N., Grundschober, C., Gee, A. D., & Tate, E. W. (2018) · Chemical Communications · doi:10.1039/c8cc01400k · Cited by 37
Can intravenous oxytocin infusion counteract hyperinflammation in COVID-19 infected patients?
Buemann, B., Marazziti, D., & Uvnäs‐Moberg, K. (2020) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2020.1814408 · Cited by 37
Eaton, J. L., & Glasgow, E. F. (2006) · Developmental Dynamics · doi:10.1002/dvdy.20848 · Cited by 37
Bernaerts, S., Boets, B., Steyaert, J. G., Wenderoth, N., & Alaerts, K. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01069-w · Cited by 36
Autism - A Neurodevelopmental Journey from Genes to Behaviour
Eapen, V. (2011) · InTech eBooks · doi:10.5772/974 · Cited by 36
An Analysis of Treatment Efficacy for Stereotyped and Repetitive Behaviors in Autism
Mulligan, S., Healy, O., Lydon, S., Moran, L., & Foody, C. (2014) · Review Journal of Autism and Developmental Disorders · doi:10.1007/s40489-014-0015-8 · Cited by 36
Secretin: Hypothalamic Distribution and Hypothesized Neuroregulatory Role in Autism
Welch, M. G., Keune, J. D., Welch-Horan, T. B., Anwar, N., Anwar, M., Ludwig, R. J., & Ruggiero, D. A. (2004) · Cellular and Molecular Neurobiology · doi:10.1023/b:cemn.0000018618.59015.a2 · Cited by 36
Slane, M. M., Lusk, L. G., Boomer, K. B., Hare, A., King, M. K., & Evans, D. W. (2014) · Developmental Cognitive Neuroscience · doi:10.1016/j.dcn.2014.04.001 · Cited by 36
Welch, M. G., Welch-Horan, T. B., Anwar, M., Anwar, N., Ludwig, R. J., & Ruggiero, D. A. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:25:3:259 · Cited by 36
Althammer, F., Jirikowski, G. F., & Grinevich, V. (2018) · Peptides · doi:10.1016/j.peptides.2018.09.003 · Cited by 35
Efficacy and safety of valproic acid versus haloperidol in patients with acute agitation
Asadollahi, S., Heidari, K., Hatamabadi, H., Vafaee, R., Yunesian, S., Azadbakht, A., & Mirmohseni, L. (2014) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000064 · Cited by 35
Brang, D., & Ramachandran, V. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2008.11.048 · Cited by 34
Association of salivary-assessed oxytocin and cortisol levels with time of night and sleep stage
Blagrove, M., Fouquet, N. C., Baird, A. L., Pace-Schott, E. F., Davies, A. C., Neuschaffer, J. L., Henley, J., Weidemann, C. T., Thome, J., McNamara, P., et al. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0880-1 · Cited by 34
The neuroevolutionary and neuroaffective psychobiology of the prosocial brain
Panksepp, J. (2012) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780198568308.013.0012 · Cited by 34
Wang, Y., Wang, M.-J., Rong, Y., He, H.-Z., & Yang, C.-J. (2019) · Research in Autism Spectrum Disorders · doi:10.1016/j.rasd.2019.03.007 · Cited by 33
The Potential of Nasal Oxytocin Administration for Remediation of Autism Spectrum Disorders
Okamoto, Y., Ishitobi, M., Wada, Y., & Kosaka, H. (2016) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527315666160413120845 · Cited by 33
Interplay between the oxytocin and opioid systems in regulating social behaviour
Putnam, P. T., & Chang, S. W. C. (2022) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2021.0050 · Cited by 34
New directions in the treatment of autism spectrum disorders from animal model research
Chadman, K. K., Guariglia, S. R., & Yoo, J. H. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.678828 · Cited by 33
Is Oxytocin Application for Autism Spectrum Disorder Evidence-Based?
Lee, S. Y., Lee, A. R., Hwangbo, R., Han, J., Hong, M., & Bahn, G. H. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.4.312 · Cited by 33
Baclofen as an adjuvant therapy for autism: a randomized, double-blind, placebo-controlled trial
Mahdavinasab, S.-M., Saghazadeh, A., Motamed-Gorji, N., Vaseghi, S., Mohammadi, M.-R., Alikhani, R., & Akhondzadeh, S. (2019) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-019-01333-5 · Cited by 32
Salcedo‐Arellano, M. J., Cabal-Herrera, A. M., Punatar, R., Clark, C. J., Romney, C. A., & Hagerman, R. J. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00968-6 · Cited by 32
Are retinoids potential therapeutic agents in disorders of social cognition including autism?
Ebstein, R. P., Mankuta, D., Yirmiya, N., & Malavasi, F. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.05.004 · Cited by 32
Neurodevelopmental Pathways to Aggression: A Model to Understand and Target Treatment in Youth
Sugden, S. G., Kile, S. J., & Hendren, R. L. (2006) · Journal of Neuropsychiatry · doi:10.1176/jnp.2006.18.3.302 · Cited by 32
Schwartz, S. S., Gallagher, R. J., & Berkson, G. (1986) · PubMed · Cited by 32
Helping behavior in prairie voles: a model of empathy and the importance of oxytocin
Kitano, K., Yamagishi, A., Horie, K., Nishimori, K., & Sato, N. (2022) · iScience · doi:10.1016/j.isci.2022.103991 · Cited by 31
Sciabola, S., Goetz, G. H., Bai, G., Rogers, B. N., Gray, D. L., Duplantier, A. J., Fonseca, K. R., Vanase-Frawley, M. A., & Kablaoui, N. M. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.05.062 · Cited by 31
Aggression and Diagnosis in Psychiatrically Referred children
Connor, D. F., & McLaughlin, T. (2006) · Child Psychiatry & Human Development · doi:10.1007/s10578-006-0015-8 · Cited by 31
Finger, E. C. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9550-2 · Cited by 30
Clinical approach to motor stereotypies in autistic children.
Ghanizadeh, A. J. (2010) · Europe PMC (PubMed Central) · Cited by 30
Perception of social interaction compresses subjective duration in an oxytocin-dependent manner
Liu, R., Yuan, X., Chen, K., Jiang, Y., & Zhou, W. (2018) · eLife · doi:10.7554/elife.32100 · Cited by 30
Modi, M. E., Majchrzak, M. J., Fonseca, K. R., Doran, A., Osgood, S., Vanase-Frawley, M., Feyfant, E., McInnes, H., Darvari, R., Buhl, D. L., et al. (2016) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.232702 · Cited by 29
Annamneedi, A., Gora, C., Dudas, A., Leray, X., Bozon, V., Crépieux, P., & Pellissier, L. P. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16216 · Cited by 29
The elusive etiology of autism: nature and nurture?
Strathearn, L. (2009) · Frontiers in Behavioral Neuroscience · doi:10.3389/neuro.08.011.2009 · Cited by 29
Asperger’s syndrome: diagnosis, comorbidity and therapy
Tarazi, F. I., Sahli, Z. T., Pleskow, J., & Mousa, S. A. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1009898 · Cited by 29
Neil, N. M., & Sturmey, P. (2013) · Review Journal of Autism and Developmental Disorders · doi:10.1007/s40489-013-0006-1 · Cited by 29
Investigation of an F-18 oxytocin receptor selective ligand via PET imaging
Smith, A. L., Freeman, S. M., Voll, R. J., Young, L. J., & Goodman, M. M. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.07.045 · Cited by 28
Allely, C. S. (2019) · Advances in Autism · doi:10.1108/aia-09-2018-0030 · Cited by 28
Sahin, H., Yücel, O., Emik, S., & Şentürk, G. E. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00124 · Cited by 28
How does epidermal pathology interact with mental state?
Denda, M., Takei, K., & Denda, S. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.11.027 · Cited by 28
Kosaki, Y., & Watanabe, S. (2016) · Behavioral Neuroscience · doi:10.1037/bne0000139 · Cited by 28
Althaus, M., Groen, Y., Wijers, A. A., Noltes, H., Tucha, O. M., Sweep, F. C. G. J., Calcagnoli, F., & Hoekstra, P. J. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4339-1 · Cited by 28
Role of Oxytocin in Different Neuropsychiatric, Neurodegenerative, and Neurodevelopmental Disorders
Ghazy, A. A., Soliman, O., Elbahnasi, A. I., Alawy, A. Y., Mansour, A. M., & Gowayed, M. A. (2022) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2022_72 · Cited by 27
Madden, A. M. K., & Zup, S. L. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.01.036 · Cited by 27
Mitchell, I., Gillespie, S. M., & Abu-Akel, A. M. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.04.018 · Cited by 27
Harrison, A. J., Gamsiz, E. D., Berkowitz, I. C., Nagpal, S., & Jerskey, B. A. (2015) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32377 · Cited by 26
Martin, M. M., Liu, Y., & Wang, Z. (2012) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.09.015 · Cited by 26
Szczepanska‐Sadowska, E. K., Wsół, A., Cudnoch‐Jędrzejewska, A., Czarzasta, K., & Żera, T. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11040908 · Cited by 26
Oral Administration of Oxytocin, Like Intranasal Administration, Decreases Top-Down Social Attention
Zhuang, Q., Zheng, X., Yao, S., Zhao, W., Becker, B., Xu, X., & Kendrick, K. M. (2022) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac059 · Cited by 27
Plasma oxytocin and personality traits in psychiatric outpatients
Bendix, M., Uvnäs‐Moberg, K., Petersson, M., Gustavsson, P. J., Svanborg, P., Åsberg, M., & Jokinen, J. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.04.003 · Cited by 26
O’Dwyer, L., Tanner, C. J., van Dongen, E. V., Greven, C. U., Bralten, J., Zwiers, M. P., Franke, B., Oosterlaan, J., Heslenfeld, D. J., Hoekstra, P. J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101130 · Cited by 26
Karpenko, J., Margathe, J., Rodriguez, T., Pflimlin, E., Dupuis, E., Hibert, M., Durroux, T., & Bonnet, D. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501395b · Cited by 26
Strathearn, L., Kim, S., Bastian, D. A., Jung, J., Iyengar, U., Martinez, S. R., Goin‐Kochel, R. P., & Fonagy, P. (2017) · Development and Psychopathology · doi:10.1017/s0954579417001018 · Cited by 26
Moy, S. S., Teng, B. L., Nikolova, V. D., Riddick, N. V., Simpson, C. D., Deusen, A. L. V., Janzen, W. P., Sassano, M. F., Pedersen, C. A., & Jarstfer, M. B. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.10.036 · Cited by 26
Roepke, S., & Vater, A. (2014) · Current Psychiatry Reports · doi:10.1007/s11920-014-0445-0 · Cited by 26
Role of Endocrine Factors in Autistic Spectrum Disorders
Tareen, R. S., & Kamboj, M. K. (2012) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2011.10.013 · Cited by 26
Frantz, M., Rodrigo, J., Boudier, L., Durroux, T., Mouillac, B., & Hibert, M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901084f · Cited by 26
Nielsen, E. I., Al-Saqi, S. H., Jonasson, A. F., & Uvnäs‐Moberg, K. (2017) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.961 · Cited by 26
Oxytocin and Prader-Willi Syndrome
Kabasakalian, A., Ferretti, C. J., & Hollander, E. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2017_28 · Cited by 26
Self-citationAdaptation and well-being : social allostasis
Schulkin, J. A. (2011) · Cited by 26
Preckel, K., Kanske, P., Singer, T., Paulus, F. M., & Krach, S. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-1036-x · Cited by 25
Ramos, L., Hicks, C., Caminer, A., Couto, K., Narlawar, R., Kassiou, M., & McGregor, I. S. (2016) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2016.10.002 · Cited by 25
Hirosawa, T., Kikuchi, M., Higashida, H., Okumura, E., Ueno, S., Shitamichi, K., Yoshimura, Y., Munesue, T., Tsubokawa, T., Haruta, Y., et al. (2012) · Scientific Reports · doi:10.1038/srep00384 · Cited by 25
Are We There Yet? The Clinical Potential of Intranasal Oxytocin in Psychiatry
Liu, J. C., McErlean, R. A., & Dadds, M. R. (2012) · Current Psychiatry Reviews · doi:10.2174/157340012798994902 · Cited by 25
Opportunities and challenges for intranasal oxytocin treatment studies in nonhuman primates
Bauman, M. D., Murai, T., Hogrefe, C. E., & Platt, M. L. (2018) · American Journal of Primatology · doi:10.1002/ajp.22913 · Cited by 25
Pharmacological treatments for personality disorders
Paris, J. (2011) · International Review of Psychiatry · doi:10.3109/09540261.2011.586993 · Cited by 25
Oxytocin and Vasopressin Stimulate Anion Secretion by Human and Porcine Vas Deferens Epithelia1
Hagedorn, T. M., Carlin, R. W., & Schultz, B. D. (2007) · Biology of Reproduction · doi:10.1095/biolreprod.106.056762 · Cited by 25
Potential for oxytocin use in children and adolescents with mental illness
Netherton, E., & Schatte, D. J. (2011) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1212 · Cited by 24
Reelin Signaling Controls the Preference for Social Novelty in Zebrafish
Vecchia, E. D., Donato, V. D., Young, A. M. J., Bene, F. D., & Norton, W. (2019) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2019.00214 · Cited by 24
Modeling Restricted Repetitive Behavior in Animals
Bechard, A. R. (2012) · Autism - Open Access · doi:10.4172/2165-7890.s1-006 · Cited by 24
Intranasal oxytocin enhances socially-reinforced learning in rhesus monkeys
Parr, L. A. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00278 · Cited by 23
L’ocytocine et la dépression du post-partum
Cardaillac, C., Rua, C., Simon, E. G., & El‐Hage, W. (2016) · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction · doi:10.1016/j.jgyn.2016.05.002 · Cited by 23
Pharmacotherapy of personality disorders
Triebwasser, J., & Siever, L. J. (2007) · Journal of Mental Health · doi:10.1080/09638230601182078 · Cited by 23
Professor Zak’s empirical studies on trust and oxytocin
Conlisk, J. (2011) · Journal of Economic Behavior & Organization · doi:10.1016/j.jebo.2011.01.002 · Cited by 22
Autism-Like Behavior in BTBR Mice Is Improved by Electroconvulsive Therapy
Hagen, E., Shprung, D., Minakova, E., Washington, J., Kumar, U., Shin, D. H., Sankar, R., & Mazarati, A. M. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0357-7 · Cited by 22
Quintana, D. S. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105642 · Cited by 22
Search for potential autism treatments turns to 'trust hormone'
Opar, A. (2008) · Nature Medicine · doi:10.1038/nm0408-353 · Cited by 22
Alaerts, K., Daniëls, N., Moerkerke, M., Evenepoel, M., Tang, T., der Donck, S. V., Chubar, V., Claes, S. J., Steyaert, J. G., Boets, B., et al. (2023) · Psychotherapy and Psychosomatics · doi:10.1159/000534114 · Cited by 21
Rao, P. D. P., & Kanwal, J. S. (2004) · Brain Behavior and Evolution · doi:10.1159/000076241 · Cited by 21
Using transgenic mouse models to study oxytocin's role in the facilitation of species propagation
Lee, H., Pagani, J. H., & Young, W. S. (2010) · Brain Research · doi:10.1016/j.brainres.2010.08.042 · Cited by 21
Controversies in autism: is a broader model of social disorders needed?
Hrdlička, M., & Dudová, I. (2013) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/1753-2000-7-9 · Cited by 21
Genetic variant rs17225178 in the ARNT2 gene is associated with Asperger Syndrome
Napoli, A. D., Warrier, V., Baron‐Cohen, S., & Chakrabarti, B. (2015) · Molecular Autism · doi:10.1186/s13229-015-0009-0 · Cited by 21
Li, J., Li, H.-X., Shou, X., Xu, X., Song, T.-J., Han, S., Zhang, R., & Han, J. (2016) · Neuropeptides · doi:10.1016/j.npep.2016.08.011 · Cited by 21
Hirosawa, T., Kikuchi, M., Ouchi, Y., Takahashi, T., Yoshimura, Y., Kosaka, H., Furutani, N., Hiraishi, H., Fukai, M., Yokokura, M., et al. (2017) · Autism Research · doi:10.1002/aur.1761 · Cited by 20
Froemke, R. C., & Carcea, I. (2017) · Principles of Gender-Specific Medicine · doi:10.1016/b978-0-12-803506-1.00037-1 · Cited by 20
Metadata
- Authors
- Hollander, E., Novotny, S., Hanratty, M., Yaffe, R., DeCaria, C. M., Aronowitz, B. R., & Mosovich, S.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Hollander, Eric
- ORCID
- Hollander, Eric
- Venue
- Neuropsychopharmacology
- Published
- 2003-01
- Volume
- 28
- Issue
- 1
- Pages
- 193-198
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2036441276
- Cited by
- 689
- References
- 60
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 15 · 2023: 15 · 2022: 23 · 2021: 22 · 2020: 27 · 2019: 15 · 2018: 29 · 2017: 33 · 2016: 47 · 2015: 49 · 2014: 49 · 2013: 51 · 2012: 44
- FWCI
- 29.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- National Institutes of Health
- National Center for Research Resources (5 M01RR00071, M01RR000071)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- oxytocin, repetitive behavior, autism spectrum disorder, Asperger syndrome, autistic adults, oxytocin infusion, vasopressin, social behavior, self-harm, need to know, ordering behavior
- MeSH terms
- Adult, Autistic Disorder, Blood Pressure, Body Temperature, Double-Blind Method, Female, Humans, Infusions, Intravenous, Male, Oxytocin, Psychiatric Status Rating Scales, Pulse, Treatment Outcome, Asperger Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
